Renin, an aspartyl proteinase involved in the regulation of cardiovascular homeostasis, exhibits tissue specific regulation. Our previous studies of the mechanisms of mouse renin gene expression using promoter-reporter gene experiments and gel mobility shift assays suggest that tissue regulated expression is dependent on a complex interaction of transcriptional factors [cAMP responsive element (CRE) binding protein and negative regulatory element (NRE) binding protein]. These trans acting factors interact with a cis acting DNA element, known as the CRE/NRE region which contains a CRE and a NRE that share an overlapping sequence. We have hypothesized that when the NRE binding protein binds to this region, renin expression is inhibited. When the CRE binding protein binds to this region, it blocks NRE binding, thereby permitting constitutive renin expression. In the kidney, CRE binding protein and NRE binding protein compete for binding to this sequence with the CRE binding protein having a greater affinity. In extrarenal sites such as submandibular gland (SMG), the NRE binding protein is able to bind effectively to the sequence, since the CRE binding protein is inactivated by an inhibitory protein that is present in the extrarenal tissue, thereby inhibiting mouse Ren-l expression. The human renin gene also contains an overlapping CRE and NRE, suggesting that its tissue expression may be regulated by similar cis- trans interactions. These data are derived from experiments using in vitro biochemical methods and noncognate cell systems and need to be verified in vivo. In this proposal, we plan to elucidate the molecular mechanism of tissue regulated renin gene expression in mouse and human at the cell and in vivo levels using cognate cell culture systems and an in vivo gene transfer approach. These studies will be performed in renin expressing cells in culture derived from mouse SMG and kidney as well as a human leiomyosarcoma cell line and primary cultures of human choriodecidual cells. In vivo, we will examine tissue renin expression in mouse SMG and kidney. We will test the hypothesis that the relative activity of the CRE binding protein vs. the NRE binding protein in specific tissues regulates renin gene expression via their competition for the overlapping sequence; and that the mutations of the promoter region that affect the function of CRE and/or the NRE will result in alterations in tissue regulated expression. Both the cell culture studies and the in vivo studies will be performed using a combination of gene transfer techniques and """"""""decoy"""""""" approach to test the hypothesis. In summary, the above studies will employ cognate cell culture and in vivo gene transfer to examine tissue regulated expression of renin in mouse and human. The performance of these experiments is a logical extension of the previous in vitro/biochemical studies and will provide an understanding of the mechanism of tissue regulated expression of renin.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37HL035610-11
Application #
2217862
Study Section
Experimental Cardiovascular Sciences Study Section (ECS)
Project Start
1985-09-30
Project End
1998-03-31
Budget Start
1995-04-01
Budget End
1996-03-31
Support Year
11
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Stanford University
Department
Surgery
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Gnecchi, Massimiliano; He, Huamei; Melo, Luis G et al. (2009) Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction. Stem Cells 27:971-9
Ip, James E; Wu, Yaojiong; Huang, Jing et al. (2007) Mesenchymal stem cells use integrin beta1 not CXC chemokine receptor 4 for myocardial migration and engraftment. Mol Biol Cell 18:2873-82
Noiseux, Nicolas; Gnecchi, Massimiliano; Lopez-Ilasaca, Marco et al. (2006) Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther 14:840-50
Gnecchi, Massimiliano; He, Huamei; Noiseux, Nicolas et al. (2006) Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 20:661-9
Wu, Yaojiong; Ip, James E; Huang, Jing et al. (2006) Essential role of ICAM-1/CD18 in mediating EPC recruitment, angiogenesis, and repair to the infarcted myocardium. Circ Res 99:315-22
Pachori, Alok S; Melo, Luis G; Zhang, Lunan et al. (2006) Chronic recurrent myocardial ischemic injury is significantly attenuated by pre-emptive adeno-associated virus heme oxygenase-1 gene delivery. J Am Coll Cardiol 47:635-43
Mirotsou, Maria; Dzau, Victor J; Pratt, Richard E et al. (2006) Physiological genomics of cardiac disease: quantitative relationships between gene expression and left ventricular hypertrophy. Physiol Genomics 27:86-94
Liu, Xiaoli; Pachori, Alok S; Ward, Christopher A et al. (2006) Heme oxygenase-1 (HO-1) inhibits postmyocardial infarct remodeling and restores ventricular function. FASEB J 20:207-16
Cunha-Neto, Edecio; Dzau, Victor J; Allen, Paul D et al. (2005) Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy. Am J Pathol 167:305-13
Gnecchi, Massimiliano; He, Huamei; Liang, Olin D et al. (2005) Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11:367-8

Showing the most recent 10 out of 193 publications